Neurontin (Gabapentin)

Gabapentin, the active ingredient in Neurontin, is a gabapentinoid presented as an oral tablet for oral use. It effectively treats partial seizures, postherpetic neuralgia, diabetic peripheral neuropathy pain, and restless legs syndrome in suitable patients.

GNH USA supplies Neurontin as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics across Europe and other global markets, ensuring quality and regulatory conformity for patients worldwide.

Gabapentin is prescribed to manage several neurological and pain‑related conditions that involve abnormal nerve signaling or hypersensitivity. - Partial seizures: reduces seizure frequency when used as adjunct therapy in patients with focal epilepsy. - Postherpetic neuralgia: alleviates chronic pain persisting after shingles, improving quality of life. - Diabetic peripheral neuropathy: decreases neuropathic pain intensity and improves sensory function in diabetic patients. - Restless legs syndrome: improves uncomfortable leg sensations and sleep quality in affected individuals. - Peripheral nerve injury pain: reduces neuropathic pain symptoms following nerve trauma or surgery.

Gabapentin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness that may affect balance. - Somnolence: increased sleepiness or fatigue, especially after the first doses. - Peripheral edema: swelling of the lower limbs, often mild but sometimes noticeable. - Weight gain: gradual increase in body weight, potentially linked to fluid retention. - Dry mouth: reduced salivation leading to a feeling of thirst.

Serious or Rare Side Effects: - Severe allergic reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts: emergence of depression or suicidal ideation. - Respiratory depression: slowed breathing, especially when combined with other depressants.

When prescribing gabapentin, clinicians should consider several safety factors. - Renal impairment: dose adjustment may be required to avoid accumulation. - Pregnancy: category B; use only if the potential benefit justifies the potential risk. - Elderly patients: monitor closely for increased sedation and falls. - Concomitant CNS depressants: may enhance drowsiness and respiratory effects. - Store at ambient temperature: keep in the original pack, protect from moisture.

Gabapentin can interact with other medicines, necessitating careful management.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce gabapentin absorption. - Opioids: increased risk of respiratory depression. - CNS depressants (benzodiazepines, alcohol): additive sedation and impairment.

Moderate Interactions (Monitor Closely): - Diuretics: may increase gabapentin plasma levels. - ACE inhibitors: monitor renal function during combined use. - Carbamazepine: may decrease gabapentin efficacy.